(Q42269692)

19 October 2017

Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study (English)

1 reference

19 October 2017

1 reference

1 reference

Daniel M Musher

1

1 reference

19 October 2017

Ingrid L Roig

2

1 reference

19 October 2017

Guillermo Cazares

3

1 reference

19 October 2017

Charles E Stager

4

1 reference

19 October 2017

Nancy Logan

5

1 reference

19 October 2017

Hossam Safar

6

1 reference

19 October 2017

19 March 2013

1 reference

19 October 2017

1 reference

19 October 2017

67

1 reference

19 October 2017

1

1 reference

19 October 2017

11-18

1 reference

Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.

19 October 2017

1 reference

12 December 2020

Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile

1 reference

12 December 2020

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific streptococcus pneumoniae antigen in urine samples

1 reference

12 December 2020

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

1 reference

12 December 2020

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

12 December 2020

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives

1 reference

12 December 2020

Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness

1 reference

12 December 2020

Influence of age on symptoms at presentation in patients with community-acquired pneumonia

1 reference

12 December 2020

Impact of respiratory virus infections on persons with chronic underlying conditions

1 reference

12 December 2020

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

1 reference

12 December 2020

Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults--Swedish Society of Infectious Diseases 2012

1 reference

12 December 2020

The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.

1 reference

12 December 2020

Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia.

1 reference

12 December 2020

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia

1 reference

12 December 2020

Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule

1 reference

12 December 2020

Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.

1 reference

12 December 2020

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

12 December 2020

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

12 December 2020

Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection

1 reference

12 December 2020

Respiratory viruses in adults with community-acquired pneumonia.

1 reference

12 December 2020

Guideline tyranny: primum non nocere

1 reference

12 December 2020

Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.

1 reference

12 December 2020

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

1 reference

12 December 2020

Management of Community-acquired Pneumonia in Adults

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

New directions for future studies of community-acquired pneumonia: optimizing impact on patient care

1 reference

12 December 2020

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

1 reference

12 December 2020

Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study

1 reference

12 December 2020

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

12 December 2020

Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis

1 reference

12 December 2020

Bacterial pathogens and death during the 1918 influenza pandemic.

1 reference

12 December 2020

Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).

1 reference

12 December 2020

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

1 reference

12 December 2020

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

12 December 2020

Absence of leukocytosis in bacteraemic pneumococcal pneumonia

1 reference

12 December 2020

Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis

1 reference

12 December 2020

Pay for performance for antibiotic timing in pneumonia: caveat emptor

1 reference

12 December 2020

Comparison of diagnostic tools with multiplex polymerase chain reaction for pediatric lower respiratory tract infection: a single center study

1 reference

12 December 2020

Severe Community-Acquired Pneumonia

1 reference

12 December 2020

10.1016/J.JINF.2013.03.003

Identifiers

DOI

1 reference

19 October 2017

1 reference